Clinical trial
Clinical Evaluation of the Efficacy of Methylnaltrexone in Resolving Constipation Induced by Different Opioid Subtypes, Combined With Laboratory Analysis of Immunomodulatory and Antiangiogenic Effects of Methylnaltrexone
NCT01955213 is registered in ClinicalTrials.gov with Amsterdam UMC, location VUmc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Evaluation of the Efficacy of Methylnaltrexone in Resolving Constipation Induced by Different Opioid Subtypes, Combined With Laboratory Analysis of Immunomodulatory and Antiangiogenic Effects of Methylnaltrexone
- Lead sponsor
- Amsterdam UMC, location VUmc
- Phase
- Observational
- Overall status
- Terminated
- Start date
- July 31, 2012
- Completion date
- September 30, 2017
- Enrollment
- 7 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.